First Department of Internal Medicine, Gifu University Hospital, Gifu 501-1194, Japan.
Endoscopy. 2013;45(3):195-201. doi: 10.1055/s-0032-1325988. Epub 2013 Jan 8.
The aim of the current study was to assess the detection rate of the right adrenal gland and the diagnostic ability of endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) for the diagnosis of adrenal metastasis in potentially resectable lung cancer.
This retrospective cohort study included a consecutive series of 150 patients undergoing EUS/EUS - FNA for staging of lung cancer. The detection rate of the right adrenal gland by EUS and the diagnostic accuracies of computed tomography (CT), positron emission tomography-CT (PET-CT), and EUS/EUS - FNA for the diagnosis of adrenal metastasis were evaluated.
The right adrenal gland was visualized by EUS in 131 patients (87.3 %); the left adrenal gland was visualized in all patients. Findings suggestive of metastasis in either one of the adrenal glands or in both were observed in 6 patients (4.0 %) by CT, in 5 patients (3.3 %) by PET-CT, and in 11 patients (7.3 %) by EUS. EUS - FNA was performed simultaneously in the 11 patients, and in 4 patients the diagnosis of metastasis was established. The accuracy for the diagnosis of adrenal metastasis was 100 % for EUS/EUS - FNA, 96.0 % for CT, and 97.0 % for PET-CT (P = 0.1146).
As well as the left adrenal gland, the right adrenal gland was also usually visible by EUS. EUS/EUS - FNA provided an accurate diagnosis of adrenal metastasis, although the prevalence of adrenal metastasis was relatively low in these patients with potentially resectable lung cancer.
本研究旨在评估内镜超声(EUS)和细针抽吸(FNA)对潜在可切除肺癌患者肾上腺转移的诊断能力,并评估其对右肾上腺的检出率。
本回顾性队列研究纳入了 150 例行 EUS/FNA 分期肺癌的连续患者。评估 EUS 对右肾上腺的检出率,以及 CT、正电子发射断层扫描-CT(PET-CT)和 EUS/FNA 对诊断肾上腺转移的准确性。
EUS 可显示 131 例患者(87.3%)的右肾上腺,所有患者均能显示左肾上腺。CT 发现单侧或双侧肾上腺有转移迹象的患者有 6 例(4.0%),PET-CT 有 5 例(3.3%),EUS 有 11 例(7.3%)。EUS 同时对 11 例患者进行了 FNA,其中 4 例诊断为转移。EUS/FNA 对肾上腺转移的诊断准确性为 100%,CT 为 96.0%,PET-CT 为 97.0%(P=0.1146)。
EUS 不仅能显示左肾上腺,通常也能显示右肾上腺。EUS/FNA 能准确诊断肾上腺转移,尽管这些潜在可切除肺癌患者的肾上腺转移率相对较低。